Boost influenza immunization uptake in your practice and find out more about standard- versus high-dose vaccine in your older patients by tuning in to this free AAFP webinar, moderated by family physician Thomas Koinis, M.D.
Download the 2015-2016 recommendations for prevention and control of influenza with vaccines.
Read a letter issued by the Department of Health and Human Services in conjunction with the AAFP and other organizations urging health care providers to recommend that pregnant and postpartum women receive the influenza vaccine.
Influenza Prevention Recommendations
The AAFP recommends that physicians offer influenza vaccination as soon as it becomes available each year and continue to provide the vaccine throughout the flu season (i.e., as long as influenza viruses are circulating in the community).
The AAFP has adopted the 2015-2016 recommendations(www.cdc.gov) for the prevention and control of influenza with vaccines, which are consistent with that of the Advisory Committee on Immunization Practices (ACIP)(www.cdc.gov).
Routine annual influenza vaccination is recommended for all persons aged 6 months and older who do not have contraindications.
The AAFP recommends that healthy children aged 2 through 8 years who have no contraindications or precautions receive live attenuated vaccine (LAIV) or inactivated influenza vaccine (IIV). There is no preference expressed for LAIV or IIV, for any person ages 2 through 49 years for whom either vaccine is appropriate. For more information, vew the 2015-2016 ACIP Influenza Vaccine Dosing Algorithm for Children Aged 6 Months Through 8 Years(www.cdc.gov).
The influenza vaccine is the first step to prevent the flu, and your recommendation can make a difference. Consider the following points in discussions with patients:
The AAFP supports annual mandatory influenza immunization for health care personnel (HCP) except for religious or medical reasons (not personal preferences). If HCP are not vaccinated, policies to adjust practice activities during flu season are appropriate (e.g. wear masks, refrain from direct patient care). (Board Chair approved June, 2011)
Trivalent recombinant influenza vaccine (RIV3) is considered egg-free and may be given to persons aged 18 years and older who have no other contraindications.
Persons who have experienced only hives after exposure to egg should receive the influenza vaccine, either with RIV3 or inactivated vaccines. If the inactivated vaccine is used, the vaccine should be administered by health care providers familiar with the potential signs and symptoms of egg allergy, and the patient should be observed for ≥ 30 minutes after vaccine administration. Persons who have had angioedema, respiratory distress, lightheadedness, recurrent emesis, or have required emergency medical intervention after exposure to egg may receive RIV3 if they are 18 years and older without contraindications. If RIV3 is not available, or the patient is not eligible for RIV3, inactivated influenza vaccine should be administered by a physician with experience in the recognition and management of severe allergic reactions. For more information, view the 2015-2016 ACIP Recommendations Regarding Influenza Vaccination of Persons Who Report Allergy to Eggs(www.cdc.gov).
This protocol assists physicians and health care professionals in the management of the expected surge of patients during an influenza pandemic. Download the protocol algorithm(2 page PDF).
The American Academy of Family Physicians (AAFP) works collaboratively with the ACIP(www.cdc.gov), which advises the Centers for Disease Control and Prevention(www.cdc.gov) on immunizations.
Share this page
Alert: Message field is required.
You must sign in before you can share a page on AAFP connection.